APA (7th ed.) Citation

Dhaenens, B. A. E., Heimann, G., Bakker, A., Nievo, M., Ferner, R. E., Evans, D. G., . . . Gross, A. (2024). Platform trial design for neurofibromatosis type 1, NF2-related schwannomatosis and non-NF2-related schwannomatosis: A potential model for rare diseases. Neuro-Oncology Practice, 11(4), 395. https://doi.org/10.1093/nop/npae001

Chicago Style (17th ed.) Citation

Dhaenens, Britt A E., et al. "Platform Trial Design for Neurofibromatosis Type 1, NF2-related Schwannomatosis and Non-NF2-related Schwannomatosis: A Potential Model for Rare Diseases." Neuro-Oncology Practice 11, no. 4 (2024): 395. https://doi.org/10.1093/nop/npae001.

MLA (9th ed.) Citation

Dhaenens, Britt A E., et al. "Platform Trial Design for Neurofibromatosis Type 1, NF2-related Schwannomatosis and Non-NF2-related Schwannomatosis: A Potential Model for Rare Diseases." Neuro-Oncology Practice, vol. 11, no. 4, 2024, p. 395, https://doi.org/10.1093/nop/npae001.